![is mounjaro a glp-1 (tirzepatide) dual incretin agonist targeting both and GIP receptors. It improves glycaemic control by enhancing insulin secretion, suppressing glucagon, and delaying gastric emptying — which also leads to Limited Offer] GIP / GLP-1](https://lookaside.instagram.com/seo/google_widget/crawler/?media_id=3876467096636489711)
is mounjaro a glp-1
Shipping Estimate
is mounjaro a glp-1 (tirzepatide) dual incretin agonist targeting both and GIP receptors. It improves glycaemic control by enhancing insulin secretion, suppressing glucagon, and delaying gastric emptying — which also leads to Limited Offer] GIP / GLP-1
EUR21.52
EUR42.52
Pay in 4 interest-free payments of $5.38 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
![is mounjaro a glp-1 (tirzepatide) dual incretin agonist targeting both and GIP receptors. It improves glycaemic control by enhancing insulin secretion, suppressing glucagon, and delaying gastric emptying which also leads to Limited Offer] GIP / GLP-1](https://www.luxora.shop/cdn/shop/files/Gemini_Generated_Image_p756i4p756i4p756.png?v=1775532162&width=480)
![is mounjaro a glp-1 (tirzepatide) dual incretin agonist targeting both and GIP receptors. It improves glycaemic control by enhancing insulin secretion, suppressing glucagon, and delaying gastric emptying which also leads to Limited Offer] GIP / GLP-1](https://annandaleprimarycare.com/wp-content/uploads/2025/06/shutterstock_2362388633.jpg)
![is mounjaro a glp-1 (tirzepatide) dual incretin agonist targeting both and GIP receptors. It improves glycaemic control by enhancing insulin secretion, suppressing glucagon, and delaying gastric emptying which also leads to Limited Offer] GIP / GLP-1](https://i.guim.co.uk/img/media/0e9dbb52876f6cb9cfbc1cfedafddfe78f6dd6bc/510_0_7655_6124/master/7655.jpg?width=465&dpr=1&s=none&crop=none)
![is mounjaro a glp-1 (tirzepatide) dual incretin agonist targeting both and GIP receptors. It improves glycaemic control by enhancing insulin secretion, suppressing glucagon, and delaying gastric emptying which also leads to Limited Offer] GIP / GLP-1](https://lirp.cdn-website.com/66c39e63/dms3rep/multi/opt/Picture2-640w.png)
![is mounjaro a glp-1 (tirzepatide) dual incretin agonist targeting both and GIP receptors. It improves glycaemic control by enhancing insulin secretion, suppressing glucagon, and delaying gastric emptying which also leads to Limited Offer] GIP / GLP-1](https://media.post.rvohealth.io/wp-content/uploads/sites/3/2025/10/Mounjaro-packaging-1296x728-header-1024x575.jpg)
![is mounjaro a glp-1 (tirzepatide) dual incretin agonist targeting both and GIP receptors. It improves glycaemic control by enhancing insulin secretion, suppressing glucagon, and delaying gastric emptying which also leads to Limited Offer] GIP / GLP-1](https://cdn.shopify.com/s/files/1/0681/6887/6288/files/common-side-effects-of-mounjaro.webp?v=1751290094)
